http://purl.org/np/RAvY9t5laZjJ9Hspb9WDhWK1bQfCcS708Yfj_kgL6dknc#Head http://purl.org/np/RAvY9t5laZjJ9Hspb9WDhWK1bQfCcS708Yfj_kgL6dknc http://www.nanopub.org/nschema#hasAssertion http://purl.org/np/RAvY9t5laZjJ9Hspb9WDhWK1bQfCcS708Yfj_kgL6dknc#assertion http://purl.org/np/RAvY9t5laZjJ9Hspb9WDhWK1bQfCcS708Yfj_kgL6dknc http://www.nanopub.org/nschema#hasProvenance http://purl.org/np/RAvY9t5laZjJ9Hspb9WDhWK1bQfCcS708Yfj_kgL6dknc#provenance http://purl.org/np/RAvY9t5laZjJ9Hspb9WDhWK1bQfCcS708Yfj_kgL6dknc http://www.nanopub.org/nschema#hasPublicationInfo http://purl.org/np/RAvY9t5laZjJ9Hspb9WDhWK1bQfCcS708Yfj_kgL6dknc#pubinfo http://purl.org/np/RAvY9t5laZjJ9Hspb9WDhWK1bQfCcS708Yfj_kgL6dknc http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://purl.org/np/RAvY9t5laZjJ9Hspb9WDhWK1bQfCcS708Yfj_kgL6dknc#assertion http://purl.obolibrary.org/obo/DOID_10763 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Disease http://purl.org/np/RAvY9t5laZjJ9Hspb9WDhWK1bQfCcS708Yfj_kgL6dknc#association http://www.w3.org/1999/02/22-rdf-syntax-ns#object http://purl.obolibrary.org/obo/DOID_10763 http://purl.org/np/RAvY9t5laZjJ9Hspb9WDhWK1bQfCcS708Yfj_kgL6dknc#association http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate https://w3id.org/biolink/vocab/treats http://purl.org/np/RAvY9t5laZjJ9Hspb9WDhWK1bQfCcS708Yfj_kgL6dknc#association http://www.w3.org/1999/02/22-rdf-syntax-ns#subject https://identifiers.org/drugbank:DB01200 http://purl.org/np/RAvY9t5laZjJ9Hspb9WDhWK1bQfCcS708Yfj_kgL6dknc#association http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement http://purl.org/np/RAvY9t5laZjJ9Hspb9WDhWK1bQfCcS708Yfj_kgL6dknc#association http://www.w3.org/2000/01/rdf-schema#label "Uncontrolled hypertension and sensitivity to any ergot alkaloids. In patients being treated for hyperprolactinemia, bromocriptine mesylate tablets and capsules should be withdrawn when pregnancy is diagnosed (see PRECAUTIONS: Hyperprolactinemic States PRECAUTIONS: Hyperprolactinemic States The drug should not be used during the postpartum period in women with a history of coronary artery disease and other severe cardiovascular conditions unless withdrawal is considered medically contraindicated. If the drug is used in the postpartum period the patient should be observed with caution." http://purl.org/np/RAvY9t5laZjJ9Hspb9WDhWK1bQfCcS708Yfj_kgL6dknc#association https://w3id.org/biolink/vocab/provided_by https://w3id.org/um/NeuroDKG http://purl.org/np/RAvY9t5laZjJ9Hspb9WDhWK1bQfCcS708Yfj_kgL6dknc#association https://w3id.org/biolink/vocab/relation https://schema.org/MedicalContraindication https://identifiers.org/drugbank:DB01200 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Drug http://purl.org/np/RAvY9t5laZjJ9Hspb9WDhWK1bQfCcS708Yfj_kgL6dknc#provenance http://purl.org/np/RAvY9t5laZjJ9Hspb9WDhWK1bQfCcS708Yfj_kgL6dknc#assertion http://www.w3.org/ns/prov#wasAttributedTo https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RAvY9t5laZjJ9Hspb9WDhWK1bQfCcS708Yfj_kgL6dknc#pubinfo http://purl.org/np/RAvY9t5laZjJ9Hspb9WDhWK1bQfCcS708Yfj_kgL6dknc#sig http://purl.org/nanopub/x/hasAlgorithm RSA http://purl.org/np/RAvY9t5laZjJ9Hspb9WDhWK1bQfCcS708Yfj_kgL6dknc#sig http://purl.org/nanopub/x/hasPublicKey MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB http://purl.org/np/RAvY9t5laZjJ9Hspb9WDhWK1bQfCcS708Yfj_kgL6dknc#sig http://purl.org/nanopub/x/hasSignature YxeSY8iY0XO57F+nVjkDcU9HRqejKyAI0bnx7wa0WaSkX7/dda0maKvNCqy6PINzZFMjXFnbO3UayXm3qPTNQoDZl+labEhSzVboMp8xPuW+boo8AbiRtVDp8tEca4q//lH1omBEIwMiqSIfsANcs+XoRFge/OGfvAeTVxvwvg8= http://purl.org/np/RAvY9t5laZjJ9Hspb9WDhWK1bQfCcS708Yfj_kgL6dknc#sig http://purl.org/nanopub/x/hasSignatureTarget http://purl.org/np/RAvY9t5laZjJ9Hspb9WDhWK1bQfCcS708Yfj_kgL6dknc http://purl.org/np/RAvY9t5laZjJ9Hspb9WDhWK1bQfCcS708Yfj_kgL6dknc http://purl.org/dc/terms/created 2021-08-23T13:10:25.375+02:00 http://purl.org/np/RAvY9t5laZjJ9Hspb9WDhWK1bQfCcS708Yfj_kgL6dknc http://purl.org/dc/terms/creator https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RAvY9t5laZjJ9Hspb9WDhWK1bQfCcS708Yfj_kgL6dknc https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM http://purl.org/np/RAvY9t5laZjJ9Hspb9WDhWK1bQfCcS708Yfj_kgL6dknc https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM http://purl.org/np/RAvY9t5laZjJ9Hspb9WDhWK1bQfCcS708Yfj_kgL6dknc https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate http://purl.org/np/RAhNHZw6Urw_Mccs4qy6Ws3C9CRuaHpQx8AwuApbWkqnY